DoubleTite

As the global aesthetic medicine market continues to evolve, clinics and distributors are increasingly seeking technologies that go beyond incremental improvements and offer true clinical differentiation. In this highly competitive landscape, Agnes Medical, a South Korea–based, dermatologist-founded company, has emerged as a key innovator with its next-generation RF microneedling system, DoubleTite.

A Dermatologist-Founded Company Built on Scientific Integrity

Agnes Medical was founded by board-certified dermatologists who clearly understand the clinical challenges and unmet needs within aesthetic dermatology. The company’s board and R&D leadership are composed largely of dermatology experts, ensuring that product development is grounded in science rather than marketing trends.

Notably, Agnes Medical is a spin-off from one of South Korea’s largest cosmetic corporations—an organization that was valued and acquired by L’Oréal for approximately USD 500 million. This heritage reflects a deep-rooted culture of research excellence, strict quality control, and global regulatory awareness.

Introducing DoubleTite: A New Standard in RF Microneedling

DoubleTite is an advanced RF microneedling device designed to treat the skin more comprehensively than conventional systems. Unlike traditional RF devices that focus primarily on the deep dermis, DoubleTite simultaneously targets two critical dermal layers:

Papillary Dermis (DP)
Reticular Dermis (DR)

This dual-layer approach represents a significant advancement in skin rejuvenation technology.

Why the Papillary Dermis Matters

Recent dermatological research has highlighted the Papillary Dermis as a key contributor to the aging process. Although this layer is extremely thin—approximately 0.3 mm—it contains Type III collagen, often referred to as “Baby Collagen,” as well as specialized fibroblasts that differ structurally and functionally from those in the deeper dermis.

While most RF microneedling systems overlook this layer, DoubleTite is the world’s first system engineered to precisely target the Papillary Dermis, actively stimulating Type III collagen regeneration and fibroblast activity. This results in faster onset of results, improved skin texture, and more natural-looking rejuvenation.

Patented Polygonal Blade Technology for Uniform Energy Delivery

In RF microneedling, it is a well-established physical principle that thermal energy is delivered primarily at the edges of the needle, commonly referred to as the Edge Effect. Many conventional devices concentrate RF energy only at the needle tip, which can lead to uneven dermal heating and inconsistent outcomes.

DoubleTite overcomes this limitation through its patented Polygonal Blade design. Instead of a round needle, the blade features six distinct edges across all sides of the needle, allowing RF energy to be distributed evenly throughout the dermis. This design minimizes localized overheating, enhances safety, and ensures predictable and reproducible clinical results.

Proven Clinical Results and Global Market Adoption

Clinical before-and-after results demonstrate that DoubleTite consistently outperforms conventional RF microneedling systems in skin tightening, texture improvement, and overall rejuvenation.

As a result, DoubleTite has gained explosive popularity in South Korea, one of the world’s most advanced and demanding aesthetic markets. Building on this success, the system is now experiencing rapid expansion in the United States, Germany, and other European markets, supported by strong clinical feedback and increasing demand.

Strategic Opportunity in the European Market

Currently, Spain does not yet have an official distributor for DoubleTite, creating a unique opportunity for a strategic partner to lead its market introduction. Market analysis conducted using Google’s AI platform (Gemini) identified DoubleTite as an ideal complementary technology for skin boosters and mesotherapy solutions, making it particularly attractive for companies already active in injectable aesthetics.

The Future of RF Microneedling

As patients increasingly demand visible results, minimal downtime, and scientifically validated treatments, technologies like DoubleTite are setting a new benchmark for RF microneedling. By combining dermatologist-led innovation, patented engineering, and proven clinical performance, DoubleTite represents a true next-generation solution in aesthetic medicine.